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OVERALL SUMMARY 
 Currently there are two types of synthetic heart valves, mechanical and bioprosthetic, 
each with certain disadvantages. The mechanical valve requires the patient to take anti-
coagulation drugs regularly and the durability of the bioprosthetic valve is relatively poor. A 
synthetic heart valve with better durability and biocompatibility is required to overcome the 
deficiencies of existing valves. Polyurethanes (PU) have been investigated in cardiovascular 
applications due to their exceptional biocompatibility, stability, and mechanical performance. 
Elast-EonTM 2A is a siloxane-based PU developed by CSIRO and commercialized by St. Jude 
medical (Abbott) for cardiac pacemaker lead insulations. Over 4 million pacemaker leads have 
been implanted in patients globally since it was introduced in 2006 and there is no reported 
insulation failure. Although mechanical properties of Elast-EonTM 2A are suitable for a range 
of medical implants, materials for synthetic heart valves require high tensile strength, high tear 
strength and low cyclic creep for long term performance. Therefore, this study was aimed at 
developing a superior material with suitable mechanical properties and biostability for 
synthetic heart valve applications and understanding their structure-property-biostability 
relationship.  
PU are comprised of non-polar soft segment and polar hard segment bonded chemically 
in alternating sequence. Mechanical properties of PU are influenced by phase separation 
between soft and hard segments triggered by their incompatibility. This study proceeded by 
hypothesising that introduction of polar functionality into the soft segment can improve the 
compatibility with relatively polar hard segment. This improved compatibility would then 
improve the creep resistance, tensile and tear strengths, while retaining long-term biostability. 
At the first stage of this study, a series of linked-macrodiols was synthesised by linking 
poly(hexamethylene oxide) (PHMO) and α,ω-bis(6-hydroxyethoxypropyl) 
poly(dimethylsiloxane) (PDMS) individually with different diisocyanates. Incorporation of 
diisocyanate in the soft segment increases the polarity and hence improve the compatibility 
with the hard segment. 4,4’-methylenediphenyl diisocyanate (MDI), isophorone diisocyanate 
(IPDI) and hexamethylene diisocyanate (HDI) were used to link macrodiols. Those linked 
macrodiols were used in synthesising a series of mixed macrodiol based siloxane poly(urethane 
urea)s (SiPUU). The hard segment was composed of MDI, and a 1:1 mixture of 1,3-bis(4-
hydroxybutyl)-1,1,3,3-tetramethyldisiloxane (BHTD) and 1,2-ethylenediamine (EDA). It was 
 xxi 
 
found that the linking of PHMO with MDI and IPDI produced SiPUU with higher creep 
resistance and higher tensile and tear strengths compared to Elast-EonTM 2A. These SiPUU 
were characterized using a suit of analytical methods including Fourier transform infrared 
spectroscopy, gel permeation chromatography, differential scanning calorimetry, dynamic 
mechanical analysis, thermogravimetric analysis, X-ray photoelectron spectroscopy, atomic 
force microscope, small and wide-angle X-ray scattering. 
The urethane linkages introduced to the soft segment by linking PHMO with MDI and 
IPDI formed stronger hydrogen bonds with urethane and urea linkages in the hard segment 
compared to that in Elast-EonTM 2A. These strong interactions enhanced the compatibility 
between soft and hard segments resulting in improved mechanical properties. Furthermore, 
PHMO-MDI-PHMO and PHMO-IPDI-PHMO linked macrodiols contributed to the mixed-
phase of SiPUU together with end groups of PDMS and some parts of hard segment. The 
linking of PHMO with MDI or IPDI reinforced this interface between soft and hard segments 
giving rise to better mechanical properties on the resultant SiPUU. All the SiPUU were non-
cytotoxic and showed siloxane-rich hydrophobic surfaces with negligible water uptake 
(0.7%/dry mass). 
Oxidative stability of two SiPUU synthesised with PHMO-MDI-PHMO and PHMO-
IPDI-PHMO linked macrodiols was evaluated by using accelerated in vitro oxidative method 
with 20% H2O2 and 0.1 mol/L CoCl2 solution which simulated the environment of human body. 
Evaluation of molecular weight, physical and chemical properties of these two materials after 
the oxidative treatment showed similar degree of resistance to environmental stress cracking 
(ESC) compared with Elast EonTM 2A. However, they showed improved resistance to ESC 
compared to polyether-PU. This study confirmed that the chemical modification in the soft 
segment did not affect the oxidative stability of SiPUU while retaining their high mechanical 
performance and long-term stability. 
Another series of SiPUU was synthesised by varying EDA:BHTD ratio. The optimum 
content of chain extender composition in the hard segment was found to be in the range of 40 
to 60-mol% BHTD in terms of higher mechanical properties. The soft segment of this series 
was comprised of PDMS and PHMO-MDI-PHMO linked macrodiol. This formulation 
produced SiPUU with high tear and tensile strengths, low modulus, high elongation and good 
oxidative stability. 
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This study provides the underpinning science together with optimised process protocols 
to design and synthesise SiPUU with high mechanical properties and good biostability for 
cardiovascular applications. Furthermore, this study provides greater insights on the structure-
property-biostability relationship of the synthesised SiPUU. Thus, this study has advanced the 
science of producing SiPUU polymers which have superior mechanical and biostability 
performance than those available commercially for heart valve leaflets. The science and 
technological process developed in this study can also be applied to formulate polymers 
suitable for other medical devices. 
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1.1 Background 
 Excellent mechanical properties, good tissue and blood compatibility, relative ease of 
tailoring properties and fabrication into devices and device components make segmented 
thermoplastic polyurethanes (PU) and poly(urethane-urea)s as the preferred materials for many 
medical applications including cardiovascular applications.1, 2 PU inherently have high 
modulus and tensile strength, toughness, elasticity, good tear strength and abrasion resistance. 
BiomerTM and PellethaneTM were the two PU introduced in 1960s for cardiovascular 
application. Since then PU have found applications in vascular grafts, catheters, casings for 
breast implants, artificial heart diaphragms, leaflet valves and drug delivery systems.3-5  
Researchers have focussed on using PU to fabricate synthetic heart valves. Currently 
there are two types of synthetic heart valves: mechanical and bioprosthetic. Mechanical valves 
are durable but lead to thrombosis and therefore patients must undertake anticoagulation 
therapy. Mechanical valves are also expensive. Bioprosthetic valves have the advantage over 
mechanical valves as they do not cause thrombosis and patients do not need to undergo 
anticoagulating treatments. However, bioprosthetic heart valves are prone to tissue failure and 
calcification. These two factors make them less durable than the mechanical valves. Therefore, 
the development of a synthetic elastomer with properties acceptable for fabrication of a heart 
valve has the potential to overcome the disadvantages of currently used mechanical and 
bioprosthetic valves.  
Siloxane polyurethanes are arguably the most biostable class of PU currently available 
for long term medical implants. Siloxane polyurethanes have been evaluated for development 
of aortic heart valves and they produced promising results in both in vitro and in vivo studies.6, 
7 These are segmented copolymers comprised of soft and hard segments. In general, the soft 
segment of siloxane polyurethanes is comprised of a mixture of poly(dimethyl siloxane) and 
either polyether or polycarbonate macrodiol and the hard segment is comprised of diisocyanate 
and chain extender. The hard segments are organised through intermolecular hydrogen bonding 
to form crystalline domains and they are dispersed within the amorphous soft segments. The 
siloxane-rich soft segment is responsible for improved biostability of siloxane polyurethanes.8 
The low surface energy of poly(dimethyl siloxane) results in surface enrichment of siloxane 
segments making the PU less susceptible to oxidative and hydrolytic degradation. Low surface 
energy of poly(dimethyl siloxane) and its poor compatibility with other polar ingredients used 
in forming the hard segment make the synthesis of siloxane-based PU more difficult. This poor 
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compatibility also resulted in highly phase separated and low molecular weight materials with 
poor mechanical properties.9-11 The lack of crystallinity and low glass transition temperature 
of the soft segment coupled with poor segmental compatibility are key contributing factors for 
the observed poor tensile properties. 
Several studies were undertaken to overcome the above problems by combining the 
favourable properties of polyurethane and poly(dimethyl siloxane).12, 13  However, these 
attempts to produce siloxane-based PU with good mechanical properties were not successful 
due to relatively nonpolar nature of poly(dimethyl siloxane). Incorporation of a second 
macrodiol as a compatibilizer improved the compatibility between soft and hard segments of 
siloxane-based PU.14, 15 Incorporation of hydrocarbon rich polyethers such as 
poly(hexamethylene oxide) (PHMO) together with α,ω-bis(6-hydroxyethoxypropyl) 
polydimethylsiloxane (PDMS) improved the compatibility between hard and soft segments and 
also produced PU with good mechanical properties and biostability.16, 17 This new generation 
of siloxane-based PU (Elast-Eon™) has been successfully used for nearly 13 years in cardiac 
pace maker lead insulation without material failure. The long-term biostability of Elast-EonTM 
was confirmed with the release of human performance data of cardiac pacemakers, for example 
OptimTM lead insulation manufactured by Abbott spanning over 7-8 years.18, 19  
The strategy of incorporating higher amount of siloxanes in the soft segment to improve 
biostability was extended to incorporate siloxanes into the hard segment. This approach has 
been explored particularly to develop low-modulus PU with good tensile strength. This has 
been achieved by combining 1,3-bis(4-hydroxybutyl)1,1,3,3-tetramethyldisiloxane (BHTD) 
and 1,4-butanediol (BDO) as chain extenders.20, 21 These studies confirmed that the 
incorporation of siloxane chain extender in hard segment improved the compatibility between 
hard and soft segments. 
However, heart valve applications require materials with improved mechanical 
properties such as low elastic modulus, high tear strength and resistance to creep deformation 
as the valve leaflets must undergo millions of open-close cycles. In addition, they require 
long-term biostability and functional performance in a dynamic environment exposed to blood. 
Long-term biostability, appropriate mechanical properties and ability to fabricate valves with 
defect free leaflets are critical for this application.  
In the context articulated above, this PhD thesis hypothesises that incorporation of polar 
functional groups in the amorphous soft segment of the poly(urethane-urea) further improve 
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the compatibility between soft and hard segments by increasing intermolecular hydrogen 
bonding. This increased hydrogen bonding is expected to greatly improve the material 
properties including tensile and tear strengths required for a material used in heart valve 
fabrication. 
1.2 Contribution to the existing field 
The outcome of this study will advance the body of knowledge by providing greater 
insights of chemical structural features of siloxane polyurethanes which are essential for 
designing PU for medical implants. These structural features reinforce the long-term 
biostability and mechanical performance of these PU. The incorporation of poly(siloxane) 
segments in PU’s structure enhances its biostability. This improvement comes with some 
degree of compromise in mechanical properties. However, these siloxanes containing PU 
remain suitable for several medical implants where the implant is not subjected to significant 
mechanical load. The mechanical properties of PU are greatly influenced by the degree of 
micro-phase separation between polar hard segments and non-polar soft segments triggered by 
their incompatibility. Therefore, an improved compatibility between hard and soft segment is 
necessary to further improve their performance. One of the advances made by this study was 
to introduction of a urethane linkage in the soft segment to enhance intermolecular hydrogen 
bonding with urethane and urea linkages in the hard segment. This hydrogen bonding increases 
the compatibility between soft and hard segments without compromising overall mechanical 
properties. 
1.3 Aim and research questions 
Aim of this study was to investigate the structure-property-biostability relationships of 
siloxane poly(urethane-urea)s (SiPUU) developed specifically to use in synthetic heart valves. 
This will be achieved by designing and synthesizing a well-defined series of SiPUU and testing 
their mechanical, thermal, and morphological properties as well as stability under simulated 
biological (in vitro) environments.  
Research Questions  
This study sought to answer the following research questions. 
1) What are the physicochemical characteristics (specifications) of SiPUU that are critical 
for optimum performance of heart valve devices?  
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2) How do the chemical composition and chemical structure of macrodiols influence the 
mechanical properties and morphology of SiPUU? 
3) How does the chemical modification in the soft segment influences the biostability of 
SiPUU? 
4) How does the chemical composition of chain extender affect the mechanical properties 
of SiPUU? 
1.4 Research objectives 
The main objectives of this study are summarised as follows.  
1) To synthesize and characterize a series of functionalized linked macrodiols to be used 
in chemical formulation of SiPUU. The incorporation of these mirodiols will improve 
the mechanical properties and stability of SiPUU. 
2) To synthesize a well-defined series of SiPUU incorporating microdiols obtained from 
objective 1 and investigate the effect of the linked macrodiols on mechanical properties 
of SiPUU. 
3) To investigate the effect of chemical structure of macrodiols on mechanical properties, 
morphology and surface properties of SiPUU (structure-property relationship). 
4) To evaluate the biostability of selected SiPUU with improved mechanical properties, 
using standard simulated in vitro test methods. 
5) To investigate the effect of the composition of chain extender in hard segment on 
physicochemical properties and biostability of SiPUU by varying the ratio of a diamine 
and a siloxane diol chain extenders.  
1.5 Thesis structure 
This thesis consists of 7 chapters. Chapter 3, Chapter 4 and Chapter 6 are published in refereed 
journals. Chapter 5 is under review in another refereed journal. The main contents of these 
chapters are briefly outlined below. 
Chapter 1: This chapter provides the background information relevant to this PhD study. It 
highlights the state of current science, gap in knowledge and the contribution of this work to 
the body of knowledge. Research aim, research questions and objectives are also documented 
in this chapter. 
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Chapter 2: This chapter provides a thorough and critical review of literature pertinent to this 
PhD thesis. It describes chemistry, morphology, synthesis and biostability of PU and 
poly(urethane urea)s. Use of different types of PU in biomedical applications are discussed. 
Siloxane-based PU and modifications used to develop materials with improved mechanical 
properties and biostability are also critically reviewed.  
Chapter 3: This chapter documents the synthesis and characterization of a series of SiPUU 
using different linkers in the soft segment. The effect of linked-macrodiol on mechanical 
properties and cytotoxicity of the materials are also discussed. The contents of this chapter 
were published as a research article.22 
Chapter 4: This chapter documents creep and recovery, morphology and surface properties of 
SiPUU synthesised with linked macrodiols. The physicochemical characteristics of SiPUU are 
compared with those of commercially available biostable siloxane polyurethane; Elast-EonTM 
2A. The contents of this chapter  have been published.23 
Chapter 5: This chapter reports the oxidative stability of SiPUU synthesised using PHMO-
MDI and PHMO-IPDI linked macrodiols, which showed improved mechanical properties with 
the modification in the soft segment. Simulated in vitro oxidative system was used to evaluate 
the stability at body temperature. The results have been compared with three different 
commercially available PU used in biomedical applications. The contents of this chapter have 
been published as a research article.24  
Chapter 6: This chapter documents synthesis of a series of linked-macrodiol based SiPUU by 
varying the composition of chain extender. It documents the effect of hard segment 
composition on mechanical properties, morphology and biostability of these materials. The 
contents of this chapter have been published.25  
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CHAPTER 2 
Literature Review 
 
 
This chapter provides a critical review of the literature studies on polyurethanes with emphasis 
on siloxane polyurethanes. Morphology, mechanical properties, formulations to study structure 
property relationships and degradation based on in vitro and in vivo data of polyurethanes have 
been critically reviewed.  
The write up in this chapter is the original work of this author and some important content of 
this literature review chapter were incorporated in an expanded and comprehensive review 
paper published by the supervisory team. The main supervisor of the candidate at CSIRO took 
the lead in this write up to expand and modify into a major review for publication in a high 
impact journal (Polymer Reviews, https://doi.org/10.1080/15583724.2018.1493694). 
Therefore, the candidate has become the second author in that review paper. 
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1. Introduction 
 Polyurethanes (PU) were first synthesised by Otto Bayer and co-workers in 1937. 
Since then this class of synthetic polymers have found many industrial applications due to the 
ability to formulate materials with a wide range of mechanical properties such as high modulus 
and tensile strength, toughness, elasticity, good tear strength and abrasion resistance. PU are 
attractive not only because of their excellent mechanical properties, but also for relative ease 
of synthesis, adaptability to a range of polymer processing techniques and the availability of a 
wide range of formulation options with different combination of starting materials. This is 
reflected in the availability of flexible foams for furniture and automotive industries, as rigid 
foams for thermal insulations, as elastomers in footwear and many other uses. The growth rate 
of global PU market started to increase in 1970’s and has been growing continuously, and 
estimated to exceed 20,000 kilo tons by 2020.1  
 Ability to formulate materials with a broad range of mechanical properties as well as 
favourable biocompatibility have attracted biomedical researchers to explore PU for 
biomedical applications. Boretos and Pierce were the first to introduce PU elastomers as 
biomaterials in 1967.2 Segmented PU elastomers have been successfully used in biomedical 
applications and some of them are artificial blood vessels, catheters, breast prosthesis, artificial 
hearts, tissue replacements and cardiac pacemaker lead insulations.3-6 BiomerTM (Ethicon 
Corporation) and PellethaneTM (Dow Chemical Corporation) were the two polyether 
polyurethanes (PEU) introduced for cardiovascular application and cardiac pacemaker lead 
insulation, respectively. In the late 1980s, pacemaker lead insulation and breast implant casings 
showed signs of failure. As a result, it was found that the polyether soft segment (SS) of PEU 
undergo oxidative degradation in the biological environment in human body.7 With the 
withdrawal of BiomerTM and PellethaneTM, several research groups focused on designing new 
PU for medical applications by changing the chemical structure of soft segment to reduce 
susceptibility to oxidative degradation. Some of the attempts included the use of chemically 
inert hydrocarbon polyols,8, 9 reduction of number of ether linkages,10  replacement of ether 
linkages with carbonate linkages11 and use of siloxane polyols in the SS.12 
 Siloxane polyurethanes (SiPU) are arguably the most biostable class of polyurethanes 
currently available for long-term medical implants. They are already in use in long-term 
medical implants such as cardiac pace maker lead insulation (Optim™ pacemaker leads by St 
Jude Medical) and recently reported eight years in human body confirming long-term 
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biostability.13, 14 SiPU have been considered for development of aortic heart valves and 
promising results are reported.15, 16 However, the long-term performance of synthetic heart 
valves is dependent on both its biostability and ability to retain mechanical properties under 
dynamic conditions. As valve leaflets must undergo millions of open-close cycles over a period 
of 25 years, fabricating valves for this purpose with long-term biostability and appropriate 
mechanical properties are critical for this application. Siloxane poly(urethane urea) (SiPUU) is 
gaining acceptance as a preferred polyurethane in biomedical implants due to its superior 
biostability compared to conventional PEU.  
2. Polyurethane Chemistry 
 PU are (AB)n type block copolymers built up of three main building blocks: 
macrodiol or polyol, diisocyanate and chain extender. Linear PU are synthesised through the 
reaction of diisocyanate and macrodiol with a chain extender in the presence or absence of 
catalyst. The chemical reaction between an isocyanate group generates urethane (carbamate) 
group. Hydroxyl or amine group generates urea groups (biuret). The polymerisation follows 
step-growth reaction kinetics, linking the building blocks through urethane linkages (-NH-
CO-O-) (Scheme 1). The reaction is exothermic and produce no by-products making the 
process attractive to scale-up production for industrial applications.   
 
 
Scheme 1. General reaction of PU formation. 
 
2.1 Chemical components of polyurethanes 
2.1.1 Macrodiol/polyol 
 Polyols or macrodiols are long-chain compounds having terminal hydroxyl groups. 
Difunctional ,-diols are typically used in formulating linear thermoplastic polyurethanes 
(TPU). These polyols are found in a range of molecular weights and 600-3000 g·mol-1 
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molecular weight range is commonly used in PU synthesis. Type and the molecular weight of 
the polyol play a major role in determining the properties of PU.17 Typically there are two main 
classes of polyols used in industrial PU, which are polyester polyols and polyether polyols.18, 
19 Table 1 lists the names and structures of some common polyols. 
 
Table 1. Names and structures of some common polyols.  
Polyol Name Structure 
 
 
Polyester 
polyols 
polyethylene 
terephthalate 
(PET) 
 
Polycaprolacto
-ne ester 
 
 
Polyether 
polyols 
Polytetramet-
hylene oxide 
(PTMO) 
 
Polypropylene 
glycol  
 
2.1.1.1 Polyester polyol 
 These are synthesized by step-growth or condensation polymerization of diols and 
corresponding dicarboxylic acids or their derivatives (Scheme 2). These are oxidatively stable 
than polyether polyols but susceptible to degradation by hydrolysis.  
 
Scheme 2. Synthesis of polyester polyol. 
2.1.1.2 Polyether polyol 
Synthesis of polyether polyol is generally carried out by ring-opening polymerization 
of corresponding cyclic ethers (Scheme 3). The reaction is initiated with compounds containing 
two or more active hydrogens (alcohols or amines) in the presence of acid or base catalyst.19, 
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20 Ethylene oxide and propylene oxide are the most commonly used epoxide with initiators 
such as ethylene glycol or propylene glycol. Poly(tetramethylene oxide) (PTMO) is one of the 
most widely used polyether polyol for making PU. It is commonly synthesized by acid 
catalysed ring-opening polymerization of tetrahydrofuran (THF). Polyether polyols are 
hydrolytically stable than polyester polyols.20  
 
Scheme 3. Acid catalysed ring-opening polymerization of THF to produce PTMO. 
 
2.1.2 Diisocyanate 
 Isocyanates are the compounds with the chemical formula of R-N=C=O 
and generally produced by reacting amines with phosgene (COCl2).      
         
                              
Scheme 4. Chemical reaction of isocyanate formation with amine and phosgene. 
 
Diisocyanates contain two –N=C=O groups and widely used in preparing PU. 
Disocyanates are very reactive compounds and prone to react with the compounds containing 
active hydrogens such as hydroxyl (-OH), amine (-NH2) and water (H2O). They react to a lesser 
extent with urea (-HNCONH-) and urethane (-NHCOO-), leading to branched products during 
polymerization. It is very important to get rid of moisture in polyols and chain extenders prior 
to use in PU synthesis to obtain a high molecular weight. Diisocyanate can be aromatic or 
aliphatic. Table 2 shows the structures of commonly used aromatic and aliphatic diisocyanates. 
Aromatic diisocyanates (MDI,TDI) are more reactive than aliphatic diisocyanates 
(HDI,CHDI).21 Aromatic diisocyanates are widely used in preparing PU for biomedical 
applications. Furthermore, the structure of the disocyanate, substituents attached, relative 
reactivity of the two NCO groups and the steric hindrance influence the polymerization reaction 
kinetics.17 
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Table 2. Names and structures of some common aliphatic and aromatic diisocyanates. 
 Name Formula Structure 
  
 A
li
p
h
a
ti
c 
 d
ii
so
cy
a
n
a
te
s 
hexamethylene 
diisocyanate (HDI) 
C8H12O2N2 OCN-(CH2)6-NCO 
isophorone 
diisocyanate (IPDI) 
C12H18O2N2 
 
dicyclohexylmethan
e 4,4'-diisocyanate 
(HMDI) 
C15H22O2N2 
 
A
ro
m
a
ti
c 
d
ii
so
cy
a
n
a
te
s 
4,4’-diphenyl 
methane 
diisocyanate (MDI) 
C15H10O2N2 
 
2,4’-diphenyl 
methane 
diisocyanate  
 
C15H10O2N2 
 
toluene 2,4-
diisocyanate (TDI) 
C9H6O2N2 
 
toluene 2,6 
diisocyanate 
 
C9H6O2N2 
 
p-tetramethylxylene 
diisocyanate  
(p-TMXDI) 
C14H16N2O2 
 
 
 
2.1.3 Chain Extenders 
 Low molecular weight diols or diamines are used as chain extenders in synthesising 
PU. Commonly used chain extenders are listed in table 3. The reaction of amino group or 
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hydroxyl group of chain extender with isocyanate produces the urea linkage or urethane linkage 
respectively to form PU or poly(urethane-urea) (PUU).18 When the functionality of the chain-
extending agent is more than two, cross-linked PU are formed.19 
Table 3. Names and structures of some common diol and diamine chain extenders. 
 Name Formula Structure 
d
io
l 
ch
a
in
 e
x
te
n
d
er
s 
1,4-butanediol 
(BDO) 
C4H10O2  
1,3-bis(4-
hydroxybutyl)1,1,
3,3-
tetramethyldisilox
ane (BHTD) 
C12H30O3Si2 
 
Ethylene glycol 
(EG) 
C2H6O2  
d
ia
m
in
e 
ch
a
in
 e
x
te
n
d
er
s 
Ethylene diamine 
(EDA) 
C2H8N2  
1,4-
butanediamine 
(BDA) 
C4H12N2 
 
Diaminopropane 
(DAP) 
C3H10N2  
1,4-
diaminobenzene 
C6H8N2 
 
 
2.2 Synthesis of Polyurethane 
There are two basic methods of preparing segmented PU; 
- One-step method 
- Two-step method (prepolymer method) 
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2.2.1 One-step method 
 This is the simplest and fastest method of preparing PU. All liquid reactants, which 
are macrodiol, diisocyanate, chain extender and the catalyst are mix at the same time at a 
desired temperature and cured overnight in a mold to obtain the polymer (Figure 1). This is 
conducted using neat reagents without using any solvent and the reaction is exothermic. 
Commonly used catalysts for this process are organotin compounds (dibutyltin dialurate, 
stannous octoate), tertiary amines or sodium and potassium salts of carboxylic acids.18, 20 
 
 
Figure 1. Schematic diagram of one-step polymerization of PU. 
 
2.2.2 Two-step/ Prepolymer method  
 Two-step polymerization is preferred when PU with better control of reaction 
exotherm and polyurethane structure are desired. Two steps are involved in formation of the 
final polymer product. Macrodiol reacts with excess isocyanate to form isocyanate end-capped 
prepolymer. In the second step diol or diamine chain extenders help to link the prepolymer 
chains through a urethane (-NH-COO-) or urea (-NH-CO-NH-)  linkage, respectively to give a 
high molecular weight PU or PUU.18 Low molecular weight diols such as 1,4-butanediol 
(BDO) or diamines like ethylene diamine are used as chain extenders. Generally, the first step 
is performed in the absence of a catalyst. The entire process can be carried out with or without 
a solvent medium. If the second step is carried out in an aprotic polar solvent, anhydrous N,N’-
dimethylformamide (DMF) and N,N’-dimethylacetamide (DMA) are good solvents. However, 
other solvents such as dimethyl sulfoxide (DMSO) and THF can also be used depending on the 
solubility. Scheme 5 shows the synthesis pathways of PU and PUU by two-step method. 
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Scheme 5. Synthesis of PU and PUU by two-step method. 
 
2.3 Polyurethane morphology 
 PU and PUU are the two main classes of polyurethane elastomers. Formation of PUU 
occurs spontaneously at room temperature, as amines are more nucleophilic than hydroxyl 
groups.22, 23 Intermolecular hydrogen bonding of urea groups plays an important role to give 
morphological characteristics to thermoplastic PUU.24 When comparing with urethane linkage, 
urea groups can form bidentate hydrogen bonding in between urea hard segments while 
urethane group can only form monodentate hydrogen bonding with each other as illustrated in 
Figure 2. Bidentate bonding is much stronger and it allows much better microphase separation. 
As a result of stronger hydrogen bonding, PUU shows some superior mechanical properties 
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such as higher tensile strength and Young’s modulus when compared to PU. Furthermore, it 
was demonstrated that the microphase separation of PUU can be improved by increasing the 
molecular weight of SS.25  
 
(a)            (b) 
Figure 2. Illustration of hydrogen bonding formation in (a) urethane (b) urea. 
 
 Diisocyanate and chain extender together considered as the hard segment (HS) 
whereas macrodiol is referred as the soft segment (SS). Those segments are chemically bonded 
as repeating units in the PU matrix (Figure 3). 
 
Figure 3. PU morphology comprising of SS and HS. 
 
 PU gains its elastomeric properties due to SS and the HS is responsible for the rigid, 
semicrystalline nature. It is important that the SS have a glass transition temperature (Tg) below 
the use temperature and HS to have Tg above the use temperature, for PU to act as an elastomer. 
Generally the HS and SS separate into domains since they are chemically incompatible and 
thermodynamically immiscible.26 This microphase separation affects the unusual mechanical 
properties, some other surface and bulk properties of PU. Microphase separation also depends 
on the nature and ratio of HS and SS, intermolecular hydrogen bonding between HS and SS, 
molecular weight of the SS and processing conditions.27-29 Therefore the structure-property 
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relationship of PU can be varied by selection of synthesis method and chemical composition 
of HS and SS.30 Microphase separation affects not only the mechanical properties, but also the 
rate and the extent of biodegradation of PU. It has been shown that the HS plays an important 
role to give additional resistance to biodegradation due to its semicrystalline morphology.7 
Morphological features of PU can be observed in detail using differential scanning calorimetry 
(DSC), small angle x-ray scattering (SAXS) wide angle x-ray scattering (WAXS), dynamic 
mechanical analysis (DMA), nuclear magnetic resonance (NMR) spectroscopy and Fourier 
transform infrared (FTIR) spectroscopy. 
2.4 Cross-linking of polyurethanes 
 Linear elastomers result by the bifunctional reactants, whereas the multi-functionality 
gives rise to the cross-linked or branched final products. Aside from that, there are three cross-
linking and branching reactions that occur in the presence of excess isocyanate to form 
allophanate, biuret and isocyanurate at desired temperatures. Further reaction of these 
trifunctional products leads to the gelation of the reaction.31 These side reactions affect the 
physical properties of the PU. 
2.4.1 Allophanate formation  
  Excess isocyanate reacts with the active hydrogen of urethane linkages and forms 
allophanates to branch or cross-link the polymer. Allophanate cross-links are thermally 
unstable and easily dissociate at higher temperatures. The stability also depends on the structure 
and aromatic allophanates dissociates at 100-120 °C and it is 85-105 °C for aliphatic 
allophanates.18 Therefore it is thermally processable and sometimes low-level of allophanate 
cross-linking is encourage to improve the mechanical properties of the final product.28 
 
Scheme 6. Allophanate formation. 
2.4.2 Biuret formation 
  Isocyanate cross-link the polymer by reacting with urea linkages and forms biuretes. 
This linkage is also likely to dissociate at higher temperatures around 115-125 °C.18 
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Scheme 7. Formation of biuret. 
2.4.3 Isocyanurate formation 
  Cyclic trimmers of isocyanate. This is preferable on heating with a basic catalyst and 
thermally stable. 
 
Scheme 8. Formation of isocyanurate. 
3. Biomedical Applications of Polyurethanes 
 The history of use of polymers in biomedical applications starts with the use of 
vulcanized natural rubber. It is crucial to have good biostability, biocompatibility and 
mechanical properties when a material is considered for use in medical implants. Even though 
different types of elastomers were used in clinical applications (some are listed in table 4), their 
use was limited due to limitations in mechanical properties, biocompatibility and 
processability.  
Table 4. Major classes of elastomers used in biomedical implants. 
Elastomer Biomedical Application 
Natural rubber Dental dams, blood pressure cuffs, 
anaesthesia masks, catheters, 
Endotracheal tubes 
Ethylene vinyl acetate (EVA) Drug delivery devices, disposable 
syringes, squeeze pumps 
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Poly(vinylchloride) (PVC) Catheters and cannula, heart and lungs 
by-pass sets, containers for blood 
Poly(isoprene) Surgical gloves, dental dams, catheters 
Poly(propylene) Hernia meshes 
Poly(dimethilsiloxane) (PDMS) Breast implants, catheters 
 
 PU grasped the attraction of biomedical researchers and widely investigated for 
biomedical applications due to relative ease of synthesis, outstanding mechanical properties 
such as high tensile strength, elasticity, toughness, good abrasion and tear resistance, fatigue 
life combined with good biocompatibility. As a class of synthetic polymers PU offer numerous 
formulation options to tailor materials to meet property specifications for different 
applications.32 
 Generally segmented TPU with aliphatic or aromatic HS and different types of 
aliphatic polyol SS, such as polyester, polyether, poly(dimethylsiloxane), polycarbonate are 
used in biomedical implantations.7 Aromatic diisocyanates are popular in biomedical 
applications as they possess good mechanical properties due to stiffness in polymer when 
compared to aliphatic isocyanates like hexamethylene diisocyanate (HDI) and 1,4 trans 
cyclohexylene diisocyanate (CHDI). 4,4’-methylenediphenyl diisocyanate (MDI) is the most 
widely used diisocayanate in these applications. 
4. Strategies to develop biostable polyurethanes  
4.1 Polyester macrodiol stability 
 Polyester SS was the first attempt of synthesising PU block copolymers for medical 
implants like breast prosthesis, catheters and blood pump diaphragms. Ester linkages were 
identified to undergo hydrolytic degradation in human body, as they absorb water due to the 
polarity of the ester linkage. Therefore, polyester polyurethanes are no longer used in long-
term medical implantations.3, 33, 34 
 
Scheme 9. Hydrolysis of ester bond in polyester macrodiol. 
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4.2 Polyether macrodiol stability 
 Hydrolysis resistant polyether SS was introduced to overcome hydrolytic degradation 
of polyester SS. PTMO was the material of choice for biomedical applications as PU and PUU 
based on PTMO exhibited excellent mechanical properties. PellethaneTM is a commercial 
polyether urethane synthesised by MDI, PTMO and BDO chain extender. Some of the 
commercially available PEU and polyether polyurethaneurea are listed in Table 5. 
Table 5. Some commercial-grade polyether urethane /polyether urethaneurea based on PTMO. 
Commercial 
Name 
Hard segment Medical applications 
PellethaneTM MDI/BDO Catheters, dialysis tubing, blood 
bags, pace maker insulations 
TecoflexTM HMDI/BDO therapeutic catheters, cardiac 
pacemaker insulation leads 
ElasthaneTM MDI/BDO Cardiac pacemaker insulation 
leads 
BiomerTM MDI/EDA coatings for left ventricular assist 
blood pumps,artificial heart, 
surfaces of cannulas,catheters, 
MitrathaneTM MDI/EDA cardiac pacemaker insulation 
leads 
 
 Generally, PU prepared by aromatic diisocyanates turns into yellow with prolong 
exposure to UV light as they consist of UV absorbing moieties and undergo auto oxidation. 
That causes loss of mechanical properties. Szycher et al. Introduced TecoflexTM, an aliphatic 
PU synthesised by using 4,4′-Methylenebis(cyclohexyl isocyanate) as an alternative for the 
biomedical application required non-yellowing and clear PU.35 Initially it was reported that 
aromatic PU form carcinogenic 4,4’-methylenedianiline (MDA) or 2,4-toluenediamine (TDA) 
during the sterilization using  -ray irradiation and autoclave.36, 37 Nonetheless, later it has been 
reported that there is no such level of MDA formation in  -ray irradiation and autoclave 
sterilization process for chain-extended TPU.38 Polyether urethaneureas were synthesised 
specially for cardiovascular applications using a diamine chain extender such as ethylene 
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diamine.39 However, use of polyether SS was also not the ideal substitution as the ether linkage 
(-CH2-O-CH2-) was susceptible to oxidative degradation.
11   
 Development of more oxidatively stable polyether macrodiol with fewer ether 
linkages; hydrocarbon macrodiol, polycarbonate macrodiol and siloxane macrodiols are some 
of the reported alternatives to reduce or prevent the susceptibility of the SS to oxidative 
degradation.28, 40 Gunatillake et al. have worked on SS with fewer ether linkages such as 
Poly(hexamethylene oxide) (PHMO), poly(decamethylene oxide) (PDMO), 
poly(octamethylene oxide) (POMO). They have shown that PU prepared from macrodiols 
having fever ether linkages to have higher resistance to degradation in biological environment 
when compared to PTMO.10, 41, 42 However, this improvement came with some compromise in 
mechanical properties, in particular the flexibility of the PU compromised when the number of 
ether linkages reduced. 
 The choice of material for long-term medical applications was a challenge as 
polyether and polyester macrodiol-based PU found to be not ideal for use in devices requiring 
long-term stability in the biological environment. Researchers investigated strategies to explore 
alternatives to polyether macrodiol to enhance biostability. These strategies helped to develop 
several macrodiols including polybutadiene, poly(isobutylene), polycarbonate, aliphatic 
haydrocarbon and polydimethyl siloxane (PDMS). 
4.3 Polycarbonate macrodiol stability 
 Use of hydrolytically and oxidatively stable polycarbonate SS was another approach 
to replace susceptible polyether SS. There were some investigations of polycarbonate 
polyurethane (PCU) with low modulus compared to the polyester PU.43 Polycarbonate SS are 
also susceptible to biodegradation due to active oxygen released by adhesive cells, but the 
degradation rate is slow when compared to PEU. Based on several in vitro and in vivo 
experiments, PCU has good mechanical strength and shown to be more biostable compared to 
PEU.11, 44-48 CorethaneTM showed 3 years of biostability both in animals and humans, being the 
first patented commercially available biostable PCU.11 CoremerTM, BionateTM, CarbothaneTM 
and CorplexTM are the other commercially available PCU.  
 Polycarbonate macrodiols can be prepared by two methods. First method is the 
polycondensation reaction of desired diols with phosgene and the other method is 
transesterification of diols with carbonates. Even though PCU showed improved short-term 
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resistance to ESC than PEU, Christenson et al. reported the enzymatic degradation of PCU by 
cholesterol esterase (CE).49 Tang et al. reported the concentration of CE plays a key role in 
biodegradation.50 It has been suggested the hydrolysis of carbonate linkage as the main reason 
for biodegradation.3 A due consideration should be given when selecting PCU for long-term 
medical implant applications 
5. Silicon Rubber and Siloxane-based Polyurethane 
5.1 Silicone Rubber 
 Silicone rubber is an elastomer which was commercially available for the first time in 
the mid 1940’s and since then have found use in a wide range of industrial applications 
including biomedical applications. These are consist of repeating units of siloxane (Figure 4). 
The two substituents (R1) are methyl (-CH3) in most common poly(siloxanes) and replacement 
of those with phenyl or fluoroalkyl groups can alter the mechanical and other properties. 
Siloxane polymers are known as polyorganosiloxane since its backbone has both inorganic and 
organic nature. 
 
Figure 4. General structure for the siloxane. 
 Siloxane polymers have low Tg of -123 °C, low surface energy, low surface tension 
(21-22 Nm/M), low moisture permeability, low solubility parameter of 15.5 (Jcm-3)1/2 as well 
as oxidation and hydrolytic stability.51 Siloxane groups can migrate to the surface of the PU 
because of the low surface energy and make a siloxane rich layer. This hydrophobic and water 
repellent surface layer acts as a protecting layer.52 Linear Polydimethylsiloxane is the most 
common siloxane and it has very poor mechanical properties in its pure form, but exhibits good 
biocompatibility and stability. Blending Polydimethylsiloxane with reinforcing fillers such as 
fine silica or chemical crosslinking improves mechanical properties for most applications 
including medical implants. Then the polymer is generally referred as ‘silicone rubber’. Silicon 
rubber has very good heat resistance and can be sterilized by autoclaving.53 Silicone rubber is 
produced as vulcanized or unvulcanised material (by Dow Corning Corporation) and widely 
used in fabricating articles for biomedical applications and in cosmetic surgery.  
 26 
 
Needles, vials and syringes used in blood collecting purposes were coated with silicone rubber 
as it delays the clotting of blood due to its excellent blood compatibility. The first successful 
prosthetic applications of silicone rubber was the use in hydrocephalus shunt to remove excess 
cerebral fluid.54 Since then many other applications of silicone rubber were found including 
plastic surgery, drug delivery, respiratory devices, orthopaedic implants, catheters and 
cardiovascular applications such as heart valves and cardiac pacemaker lead insulations.55, 56 
Even though silicone gel-filled breast implants were introduced in 1962 with a high demand, 
litigation raised regarding autoimmune connective tissue disease and breast cancers related to 
breast transplants. However, later it was proved that there is no correlation between breast 
implants and breast cancer.32, 57 In vivo degradation experiments have shown the structural 
changes of silicone rubber pace maker lead insulations resultant with decrease of mechanical 
properties.58, 59 Poor mechanical performances and processing limitations narrowed the 
applications of silicone rubber despite having excellent biocompatibility and biostability.  
5.2 Siloxane-based Polyurethanes  
 The incorporation of siloxane macrodiols has been by far the most successful 
approach in improving the degradation resistance of PU. The covalent linking of PDMS 
segments to PU has been investigated to impart some of its attractive properties such as low 
Tg, good hydrolytic and oxidative stability, good blood compatibility, low toxicity and anti-
adhesive characteristics. Yilgor et al. successfully incorporated low molecular weight α,ω-
bis(aminopropyl) polydimethylsiloxane as the end group of high molecular weight 
polyurethanes.60 
 Although the mechanical properties were somewhat compromised, SiPU exhibited a 
good balance of mechanical properties and stability.61 However, PDMS-based PU and PUU 
showed an improved resistance to biodegradation. Previous in vivo and in vitro studies have 
demonstrated that the SS derived from PDMS has improved the stability against biological 
oxidation, MIO and ESC.62, 63 Ward et al. have confirmed that the best resistance to MIO 
through cobalt ions can be achieved by substitution of 35% PDMS instead of polyether in the 
SS.64, 65  
5.2.1 Development of siloxane polyurethanes 
 The incorporation of high level of siloxane has been one of the challenges in 
developing SiPU. That is due to the incompatibility of the non-polar siloxane SS and relatively 
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polar HS derived from diisocyanate and chain extender.62 That incompatibility results in PU 
with poor mechanical properties due to high degree of phase separation. Speckhard et al.66 first 
reported on factors affecting the poor mechanical properties of PU based on non-polar soft 
segments such as PDMS. Therefore, the incorporation of siloxane segments to form part of the 
SS of the PU required strategies to overcome the incompatibility of siloxane precursors with 
other building blocks. The chemical structure of the segment linking the end-functional groups 
of PDMS influenced the properties of PDMS-based polyurethanes. Different approaches have 
been investigated to introduce polar functional groups to the siloxane SS. These different types 
of modifications helped alter physical and chemical properties of siloxane polymers according 
to their applications.  
 One main approach reported to overcome the discordancy of HS and SS was to 
introduce a polar functionality to PDMS backbone. That could be achieved by combining a 
polar segment to PDMS. Changing of substituents on the polyorganosiloxane backbone could 
be easily done and α,ω-organofunctionally terminated siloxane oligomers has been designed. 
It was an important starting material and led to the synthesis of many useful PU and PUU with 
wide range of physicochemical properties.67 As Si-O linkage having partially ionic character, 
it can be easily cleaved by acids or bases to obtain the desired α,ω-organofunctionally 
terminated siloxane. A well-known method is ring-opening polymerization with cyclic silicone 
monomers such as hexamethylcyclotrisiloxane (D3), octamethylcyclotetrasiloxane (D4) and 
decamethylcyclopentasiloxane (D5).51, 68 The general reaction is illustrated in Scheme 10. The 
product is purified by vacuum distillation to remove low molecular weight cyclics formed as 
by-products of the reaction (10-15%). 
 
 
Scheme 10. Synthesis of functionally terminated siloxane by ring opening reaction (m=1-3). 
  
 First attempt of preparing α,ω-difunctional terminated siloxane was PDMS with Si-X 
linkages at the end (Figure 5). There is a wide range of choice for X group and that can be –
OH, -Cl2, -NH2, -OCH3, -CH=CH2, or -N(CH3)2. The functional groups directly attached to Si 
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are highly reactive (except -CH=CH2) to compounds such as water and alcohol with active 
hydrogens.69  
 
Figure 5. α,ω-difunctionally Si-X terminated oligomer. 
 Another attempt to overcome the incompatibility was to include Si-O-C group in 
PDMS and that was not successful in biomedical applications, as it was susceptible to 
hydrolytic attack in the presence of water.  The researchers explored other strategies to attach 
hydroxy alkyl groups to siloxane without linking through oxygen. 
 As a result, Si-R-X end group was proposed (Figure 6). R was short chain hydrocarbon 
group. This R group affected the reactivity of terminated functional group (X) and miscibility 
of PDMS in solvents.52 The solubility of PDMS in polar solvents was enhanced by increasing 
the polarity of R group.29 Ethoxypropyl terminated PDMS is currently the most widely used 
macrodiol to improve mechanical properties of polyurethanes.  
 
Figure 6. α,ω-difunctionally Si-R-X terminated oligomer. 
 
 Table 6 shows couple of common siloxane-based polyether and alkane macrodiols. 
Hydroxyalkyl terminated Polydimethylsiloxane is the widely used macrodiol in synthesising 
siloxane-based PU and PUU. PurSilTM is commercially available polyether-siloxane PU 
comprising excellent mechanical properties compared to conventional silicone elastomers with 
good biostability and biocompatibility.  
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Table 6. Chemical structures of common siloxane macrodiols. 
Name Chemical structure 
 
𝛼,ω-
bis(hydroxyethoxypropyl)polydimethyl 
siloxane   
 
 
 
 
bis(hydroxyalkyl) terminated 
polydimethyl siloxane   
 
          
    
m = 4,5 or 6  
 
 However, poor compatibility with relatively polar HS of PU make the synthesis of 
PDMS-based PU more difficult leading to highly phase separated and brittle materials. One 
strategy to overcome this problem was to incorporate a second macrodiol as a compatibilizer 
to improve phase mixing between soft and hard segments. Nevertheless, SiPU synthesised by 
Chun et al.62 using a mixture of hydroxyl terminated PDMS and poly(propylene glycol) were 
highly phase separated and showed poor tensile properties. Gunatillake and co-workers have 
investigated this approach in detail and demonstrated that PDMS-based PU with good 
mechanical properties and biostability can be synthesized. They have used different polyether 
and polycarbonate macrodiols as the comacrodiol to synthesis a series of PU. They investigated 
that the comacrodiol affects the properties and morphology of siloxane based PU, and showed 
PHMO and PTMO were the best polyether comacrodiols for α,ω-bis(6-hydroxyethoxypropyl) 
polydimethylsiloxane (α,ω-PDMS). Results showed that incorporation of hydrocarbon rich 
polyethers such as PHMO was more significant than polycarbonates.70 Furthermore, they have 
demonstrated that low molecular weight (< 1000 g·mol-1) PHMO was the best comacrodiol 
among polyethers to combine with PDMS to have favourable compatibility with the HS. The 
formulation of 80:20 (w/w) of α,ω-PDMS:PHMO was with the best mechanical properties and 
biostability.12, 71 Moreover, the researchers reported that the method of PU synthesis affects the 
properties and morphology. The results showed that one-step bulk ploymerization can be 
carried out effectively with a tetra-coordinated tin catalyst to prepare PU with good mechanical 
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properties. Mechanical properties were poor when the HS composition increases. However, a 
drawback of this one-step method was the poor immiscibility of reactants. Two-step bulk 
polymerization could overcome that problem to some extent and ended up with the PU having 
good mechanical properties. Two-step method was also favourable for preparation of PU for 
medical implants as that can be carried out without a catalyst.12  
 This key finding in the mid 1990’s paved the way for innovation of a new generation 
of siloxane-based polyurethanes (Elast-EonTM 2A) with biostability superior to other PU 
available at the time. Elast-EonTM 2A (E2A) was commercialized by AorTech Biomaterials.72 
E2A formulation was based on 80:20 (w/w) of α,ω-PDMS:PHMO in the SS, and 40% HS with 
MDI and BDO. This material exhibited mechanical properties comparable to PellethaneTM 
80A.12 In 2006, St Jude Medical introduced Optim™ pacemaker lead insulation as the first 
medical implant application of  E2A, and over 4 million devices are currently implanted in 
patients worldwide. 
Gunatillake and collaborators also explored that the molecular weight of the SS is similarly 
responsible for the mechanical properties of a PU. It is clearly reported that  PU and PUU with 
good mechanical properties can be synthesised by using α,ω-PDMS having the molecular 
weight in between 1000-2000 g·mol-1.73 
6. Evaluation of Biostability 
 The screening of new materials for consideration for use in medical implants requires 
testing under in vitro and in vivo environments by choosing test conditions to simulate the 
biological environment. PU biodegradation in human body is a result of the direct exposure to 
cellular components released from the body to destroy the foreign materials introduced.7 Two 
main oxidative degradation pathways are Metal ion oxidation (MIO) and Environmental stress 
cracking (ESC). MIO takes place due to the oxidation catalysed by transition metal ions in 
implanted devices.64, 74-77 The implanted device releases transition metals, like Cobalt (Co) due 
to corrosion with time. These metal ions catalyse the decomposition of H2O2 producing 
hydroxyl radicals (OH•), which are strong oxidants and induce the oxidation process of PU 
leading to degradation in human body.7, 11 ESC occurs as a result of direct tissue contact and 
stress.42, 78-81 The mechanical stress built into the material during processing and/or those 
experienced by the material within the body may accelerate this process. It was found that the 
foreign body giant cells (FBGC) and adherent macrophages produced as a reaction for the 
foreign material in biological environment. They release reactive oxygen species and initiates 
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oxidative degradation.7, 82 These species are responsible for initiating chemical degradation of 
the polyurethanes. Methylene carbon adjacent to ether oxygen in polyether soft segment is 
more vulnerable to be attacked by released oxygen radicals, leading to chain scission and 
crosslinking. PU are more prone to oxidative attack when the number of ether linkages are 
higher in the SS. 
 In vitro stability tests under simulated biological conditions and accelerated 
temperatures are used to predict long-term biostability of PU.40, 83, 84 While in vitro accelerated 
tests may be useful in screening new materials, they are not a very good predictor to see how 
these materials perform in the biological environments. However, typical accelerated in vitro 
evaluation is not enough to foretell the long-term performance of a material as the response of 
the body on implanted materials is complex. Padsalgikar and collaborators have demonstrated 
the limitations of correlation of accelerated in vitro and in vivo results as the high temperatures 
affect the microstructure of PU.85 Moreover Mishra et al. have observed the mass loss of E2A 
due to thermal degradation by accelerated high temperature in vitro experiments.86 Therefore, 
animal studies are critical to evaluate and predict long-term biostability of PU. 
 Arguably, 20% H2O2 and 0.1M CoCl2 solution at 37 °C is the ideal in vitro system to 
reproduce physical and chemical in vivo environment predicting long-term stability.87, 88 Co2+ 
ions in the H2O2/CoCl2 system catalyse the decomposition of hydrogen peroxide producing 
hydroxyl radicals (HO·) to initiate degradation. However, it is much difficult to simulate the 
biological environment leading to ESC. For the reason that, there are  other species such as 
molecular oxygen and superoxides are involved in the biological environment.80 Zhao et. al. 
reported pre-treatment of test specimens in human plasma at 37˚C and exposure to H2O2/CoCl2 
solution at 50˚C can be used to produce in vitro stress cracking.79  However, this screening test 
became less attractive due to sample handling difficulties. Use of glass wool around the test 
specimens was introduced to overcome this limitation.88 It was reported that the glass wool 
enhance the retention and interaction of oxygen species with the test specimen providing a 
large surface area. Recently Gallagher et al. confirmed Zhao type glass wool method is the best 
to reproduce in vivo ESC.89 
7. Biostability of siloxane-based polyurethane 
 Stability in the biological environment is one of the most important factors for a 
material used in medical applications. The resistance of the PU to degradation in a biological 
environment is largely governed by the chemical nature of the polyol (macrodiol) forming the 
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SS component. In addition to that, effect of the chemistry of HS and morphology of the PU on 
the stability has also been investigated.90  
 Gunatillake et al. focussed on incorporation of PDMS into SS as well as into HS by 
using silicone containing chain extender and preparing of PUU with excellent mechanical 
properties and enhanced biostability.91 They demonstrated that PU with good biostability can 
be obtained with the composition of SS at least one polysiloxane macrodiol and one polyether 
or polycarbonate macrodiol, which is preferable for medical applications.72 PU were prepared 
by combining 1,3-bis(4-hydroxybutyl)1,1,3,3-tetramethyldisiloxane (BHTD) and BDO as the 
chain extenders in different ratios. DSC and DMA confirmed that the incorporation of siloxane 
chain extender in the HS decrease the incompatibility of HS and SS. The molar ratio of 60:40 
of BDO:BHTD in the MDI derived HS with  α,ω-PDMS and PHMO in the SS resulted a new 
Polyurethane (Elast-Eon TM3) with good mechanical properties and biostability.92, 93 
 Biostability of E2A has been examined by implantation of flat sheet dumbells in sheep 
for periods ranging from 3 to 24 months. It was found that the biostability of E2A was superior 
to commercially available PellethaneTM2363-80A and BionatesTM, and comparable to 
PellethaneTM2363-55D.94 Chaffin et.al. investigated the reduction of molar mass and tensile 
strength of E2A and PurSilTM35 when exposed to water. These in vitro results showed 50% 
and 67% molar mass reduction of E2A and PurSilTM35 respectively at 85 °C in phosphate 
buffered saline solution for 52 weeks.95 They have suggested nearly three years for PurSilTM35 
and six years for E2A to acquire that mass loss in human body at 37 °C. This study showed the 
probability of hydrolytic cleavage of Si-O bond of PDMS and raised the concerns over long-
term biostability of E2A. However, a recent study demonstrated the long-term biostability of 
E2A as the OptimTM cardiac pacemaker lead insulation material and attributed the observed 
mass loss of these materials is due to allophonate dissociation.14 They showed that OptimTM 
cardiac pacemaker lead insulation material do not undergo progressive in vivo degradation 
compared to PurSil TM35 (PTMO-based siloxane polyurethane), ElasthaneTM55D and 
ElasthaneTM80A (polyether polyurethanes). Another accelerated in vitro study carried out by 
Wilkoff et al. showed that there’s only about 20% of mass loss in OptimTM after 5 years with 
excellent biostability.13 E2A can be sterilized by gamma irradiation or ethylene oxide. High 
performance liquid chromatography (HPLC) did not show toxic products like MDA in aqueous 
extracts from non-sterilized, gamma-sterilized or oxidised E2A.96 
 33 
 
 PDMS end-capped PU showed enhanced in vivo biostability compared to 
conventional PEU.44 PDMS migrates to the surface due to low surface energy. It forms a 
protecting layer against oxygen radicals and reduce the rate of oxidative degradation. However, 
attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) results of the 
study showed that PDMS protecting layer is not effective enough to protect oxidatively 
susceptible polyether SS from the degradation under high strain. Ward et.al. have also shown 
that PDMS tends to gather in the surface providing a hydrophobic layer which helps to improve 
oxidative stability.97 
 Ward et al. have also been investigated in vivo and in vitro biostability of siloxane-
based PEU. Results showed that the incorporation of 20-35% polysiloxane into polyether SS 
reduced the MIO and increased the biostability over conventional PEU. They reported that 
implants of siloxane-free PEU in rabbits were intensely undergone to MIO after 2 years while 
there were only minor cracks in polyether-siloxane PU. Furthermore, those siloxane implants 
showed better auto oxidative and stress stability than conventional PU after 18 months 
implantation in rabbits.64, 65  
  There are many investigations of polycarbonate-based siloxane polyurethanes as well. 
Polycarbonate-siloxane PU are more resistive for hydrolytic degradation compared to 
polyether-siloxane PU. CarboSilTM is a commercially available polycarbonate-silicone PU with 
an outstanding biostability and biocompatibility. It has been reported that the silicone modified 
PurSilTM (polyether-silicone PU) and CarboSilTM (polycarbonate-silicone PU) have enhanced 
biostability than conventional polyether and polycarbonate PU.75 
 Ward et al. developed polycarbonate based SiPU with small percentage of additives, 
which can be used for blood and tissue-contacting medical devices.98 Moreover another study 
showed that the PU with low modulus and high tensile strength can be prepared by 
incorporation of siloxane into the polycarbonate PU structure, which enables the phase mixing 
to achieve such mechanical properties.99 Choi and coworkers also demonstrated the preparation 
of PU with enhanced phase mixing and low modulus by using mixed macrodiol based on 
polycarbonate and siloxane.5 They prepared series of PU by varying the composition of MDI 
and BDO in the HS and the molecular weight of silicone-carbonate macrodiol. The results 
exhibited that the PU prepared with 40% of HS and number average molecular weight of 600 
g·mol-1 SS diol consists of good oxidative biostabiity compared to E2A.  
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8. Polyurethanes in heart valve prosthesis 
 Several heart valve prostheses have been investigated so far and none of them was 
perfect for long-term clinical use. Major types of prosthetic heart valves are mechanical valves, 
bioprosthetic valves and synthetic valves. Mechanical valves are durable but lead to thrombosis 
and therefore patients have to be on anticoagulation therapy as long as they use the mechanical 
valve. Mechanical valves are also expensive. Bioprosthetic valves have the advantage over 
mechanical valves as they do not succumb to thrombosis and patients do not have undergo 
anticoagulating treatments.100 However, bioprosthetic heart valves are prone to tissue failure 
and calcification causing less durability. Synthetic elastomeric materials have been 
investigated to get the advantage over mechanical and biological heart valves. Silicone rubber 
and polytetrafluoroethylene were used to design valves, and both were not suitable being less 
durable.101, 102 
 Many researchers have focussed on use of polyurethanes due to their excellent 
mechanical, blood compatible and biocompatible properties for cardiovascular applications.103 
Nevertheless PU have also been reported calcification and thromboembolic problems.104 It has 
also been reported tearing of the leaflet within few millions of cycles due to poor fatigue 
resistance.105 SiPU have also been investigated for development of aortic valves and very 
promising results are reported.16 The results showed the improved durability compared to the 
bioprosthetic valves and low thromboembolic effect compared to mechanical valves. In recent 
years, there are only few investigations of SiPUU in prosthetic heart valves, but long-term 
persisting mechanical properties and biostability is still critical for aortic valve fabrication. 
9. Methods used in this thesis to synthesize a material for heart valve application 
It is important to identify the desired properties when designing a new material for a 
specific biomedical application. Those desired properties could be achieved by altering the 
chemical structure of a known material with already established properties and biostability. 
Elast-EonTM is a biostable polyurethane with good mechanical properties and its soft segment 
is derived from an 80:20 w/w mixture of α,ω-bis(6-hydroxyethoxypropyl) 
poly(dimethylsiloxane) (PDMS) and PHMO. This chemical formulation was chosen to create 
the soft segment of SiPUU and to carrying out further chemical modifications to improve 
tensile and tear strengths to meet the specified properties required for heart valve application. 
The major chemical modification used in the study was to link one of the macrodiols with a 
disocyanate in order to introduce polar functional groups to the soft segment. This approach 
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altered the phase morphology and improved the mechanical properties through enhanced 
segmental compatibility. 
In this study either PHMO or PDMS was linked with a diisocyanate to improve the 
polarity of the soft segment. A series of linked-macrodiols were synthesised individually with 
PDMS and PHMO. Three different diisocyanates 4,4’-methylenediphenyl diisocyanate (MDI), 
isophorone diisocyanate (IPDI) and hexamethylene diisocyanate (HDI) were used to link 
PHMO and PDMS macrodiols, individually. Table 7 shows the names, abbreviations and the 
structures of two macrodiols, three different diisocyanates and two chain extenders used in this 
work.  
Table 7. Names and the chemical structures of the macrodiols, diisocyanates and chain 
extenders used to synthesize siloxane poly(urethane urea (SiPUU) in this thesis. 
Name of the reagent Abbreviation Structure 
α,ω-bis(6-
hydroxyethoxypropyl) 
poly(dimethylsiloxane) 
PDMS 
 
poly(hexamethylene 
oxide) 
PHMO 
 
4,4’-
methylenediphenyl 
diisocyanate               
MDI 
 
isophorone 
diisocyanate  
IPDI 
 
hexamethylene 
diisocyanate  
HDI 
 
1,3-bis(4-
hydroxybutyl)1,1,3,3-
tetramethyldisiloxane  
BHTD 
 
Ethelene diamine EDA 
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Scheme 11 shows the reaction between MDI and PDMS to produce PDMS-MDI-
PDMS linked-macrodiol and Scheme 12 shows the reaction between MDI and PHMO to 
produce PHMO-MDI-PHMO linked-macrodiol. Similarly, another four different linked 
macrodiols (HDI-PDMS-HDI, HDI-PHMO-HDI, IPDI-PDMS-IPDI and IPDI-PHMO-IPDI) 
were synthesised by linking PHMO and PDMS separately with IPDI and HDI.  
 
 
Scheme 11. The reaction between PDMS and MDI to synthesise PDMS-MDI-PDMS 
linked macrodiol 
 
 
Scheme 12. The reaction between PHMO and MDI to synthesise PHMO-MDI-
PHMO linked macrodiol 
 
The 1,3-bis(4-hydroxybutyl)-1,1,3,3-tetramethyldisiloxane (BHTD) and 1,2- 
ethanediamine (EDA) were used as chain extenders (structures in Table 7). The choice of EDA 
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was chosen as a chain extender in order to introduce urea linkages in the hard segment to 
improve themechanical properties of SiPUU.  
Linked macrodioland unlinked other type of macrodiol were reacted with MDI and then 
chain extended with BHTD and EDA to synthesise SiPUU. Figure 7 shows the synthesis of 
SiPUU which has PDMS-MDI-PDMS linked macrodiol in the soft segment. Figure 8 shows 
the synthesis of SiPUU which has PHMO-MDI-PHMO linked macrodiol. The complete step 
by step process of the synthesis of all SiPUU are provided in the experimental section of 
Chapter 3.  It is worth noting that the chemical structure of SiPUU presented in Figure 8 
represents a generalised structure and shows how various segments are connected within the 
polymer chain. Since the reagents react randomly, the exact or fine structure of SiPUU can be 
somewhat different than the generalised structure (Figure 8). However, two molecules of 
PHMO are always linked with one single MDI unit. The characteristic structural feature of all 
SiPUU described throughout this thesis. 
 
 
 
Figure 7. Synthesis of SiPUU with PDMS-MDI-PDMS linked macrodiol 
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Figure 8. Synthesis of SiPUU with PHMO-MDI-PHMO linked-macrodiol 
 
10. Emerging applications of Siloxane Polyurethanes 
 Although the applications of SiPU may be restricted to clinical use such as 
cardiovascular applications, their unique properties are attractive for applications outside the 
medical field. One area that has attracted researchers to investigate is anti-bacterial (anti-
fouling) coatings.106-111 Settlement of marine organisms (bacteria, algae, molluscs) leads to a 
process called biofouling. This is a major problem for the maritime industry leading to 
deterioration of the surfaces, increased fuel consumption and loss of vessel manoeuvrability 
costing billions of dollars per year in transportation.112 One approach to overcome this problem 
is use of non-toxic fouling release coatings. Silicone elastomers generally have good 
antifouling properties due to low surface energy and low elastic modulus. However, direct use 
of those as anti-fouling coatings is difficult due to poor mechanical properties, particularly the 
low abrasion resistance. The SiPU formulations are different to those developed as elastomers 
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and in most cases involves some level of cross-linking to have the desired properties for surface 
coatings.  
 Several recent studies have focused on developing SiPU and SiPUU formulations with 
improved coating properties for fouling release applications in seagoing vessels. One approach 
was to development of anti-fouling coatings by grafting aminopropyl-terminated siloxane 
oligomers on to polyurethane surfaces.110, 113, 114 Another study reported on fouling release 
properties of zwitterionic siloxanepolyurethane coatings. The zwitterionic segments were 
incorporated as part of a tri-block copolymer with PDMS central block and outer zwitterionic 
block based on sulfobetaine methacrylate.115 The coatings showed excellent fouling release 
performance toward the bacteria and the diatoms. Waterborne polysiloxane-urethane urea 
systems have also been evaluated as fouling release coatings.107, 108 A combination of low 
surface energy and low modulus of the material contributed to good fouling release based on 
immersion tests in seawater. The formulations with relatively higher siloxane content gave the 
best results.  
11. Summary and Future Direction 
 Excellent mechanical properties, good tissue and blood compatibility, relative ease of 
tailoring properties and fabrication into devices and device components made segmented 
thermoplastic PU and PUU as the choice of material for many medical devices. However, PU 
undergo in vivo degradation under different conditions when implanted in human body. PEU 
were investigated to get the advantage over hydrolytically susceptible Polyester urethanes. 
PEU were prone to oxidative degradation and different strategies have been developed to 
replace oxidation-prone polyether segments and improved the long-term biostability. Even 
though polybutadiene, polycarbonate and aliphatic hydrocarbon SS were investigated to 
improve the biostability, they were not sufficient for long-standing primarily due to poor 
mechanical properties. Combining siloxane in the PU backbone was arguably the best solution 
for improving PU biostability. PDMS was used to synthesise SiPU and SiPUU for biomedical 
applications with excellent biostability and outstanding properties of PDMS. Microphase 
separation can be seen in SiPU due to the incompatibility of polar HS and non-polar SS. This 
microphase structure of SiPU influence the mechanical properties. Different methods have 
been used to introduce a polar nature to the SS of SiPU and enhance phase mixing and hence 
to improve mechanical properties. It was reported in the literature that the structure-property 
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relationship of PU depends on the chemical structure of the backbone, molecular weights and 
ratio of the soft and HS, method of synthesis and extent of phase separation. 
 Although the mechanical properties are somewhat compromised, SiPU and SiPUU 
have a range of desired mechanical properties for a range of biomedical applications. E2A is a 
family of siloxane polyurethanes developed in CSIRO and commercialized by AorTech 
Biomaterials, currently used in cardiac pacemaker insulation (St Jude Medical). While E2A 
may have the required mechanical and biostability characteristics for a range of medical 
implants, certain other applications require tailoring materials with specific properties; for 
example, cardiovascular applications such as heart valves. The material for heart valve 
application require high tensile strength, high tear strength and low cyclic creep in addition to 
long-term biostability. The demonstrated long-term biostability of SiPU in clinical applications 
may give the confidence for christinbiomedical engineers to use them in designing new medical 
implants. The improved understanding of the relationship of PU chemical structure on 
properties and biostability will help synthetic polymer chemists when designing new materials 
to suit the needs of next generation medical implants. 
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7.1 Introduction 
Structure-property-biostability relationship has been established for siloxane 
poly(urethane-urea)s (SiPUU) synthesised for cardiovascular applications such as synthetic 
heart valves. It was hypothesised that the chemical compatibility of soft and hard segments of 
polyurethanes can be improved by introducing polar functionality in the soft segment structure. 
This hypothesis was tested, confirmed and the results were documented in preceding 
experimental chapters (Chapter 3-6). The research questions posed on the outset of this study 
were answered and the objectives were addressed through the experimental data and their 
interpretation presented in these experimental chapters. Mixed macrodiol based siloxane 
polyurethanes prepared from α,ω-bis(6-hydroxyethoxypropyl) poly(dimethylsiloxane) 
(PDMS) and poly(hexamethylene oxide) (PHMO) macrodiols in 80:20 (w/w) ratio have 
already shown good combination of mechanical properties and biostability (e.g, Elast-
EonTM).1-3 Therefore, the above soft segment composition was chosen for doing further 
chemical modifications to improve tensile and tear strengths to meet the specified properties 
required for heart valve application.  
A series of linked macrodiols were synthesised individually with PDMS and PHMO. 
Three different diisocyanates 4,4’-methylenediphenyl diisocyanate (MDI), isophorone 
diisocyanate (IPDI) and hexamethylene diisocyanate (HDI) were used to link PHMO and 
PDMS macrodiols, individually. MDI is an aromatic diisocyanate while both HDI and IPDI 
are aliphatic diisocyanates.  The isocyanate groups in IPDI are sterically hindered. These 
linked-macrodiols were used in synthesising SiPUU. The 1,3-bis(4-hydroxybutyl)-1,1,3,3-
tetramethyldisiloxane (BHTD) and 1,2- ethanediamine (EDA) were used as chain extenders. 
The choice of EDA as a chain extender was to introduce urea linkages in the hard segment to 
improve mechanical properties.  
The SiPUU synthesised in this work was characterised using a number of physical and 
chemical test methods. Measurement and interpretation of tensile properties formed a major 
part of this thesis. Several of the SiPUU synthesised in this work had improved tensile 
properties compared to Elast-EonTM. In vitro oxidative stability of SiPUU was evaluated and 
the results were compared with commercially available siloxane polyurethanes used in 
biomedical applications (Elast-EonTM 2A, ChronoThane PTM and ChronoSilTM). Finally, the 
effect of composition of hard segment on the morphology, tensile properties and biostability 
of SiPUU was measured and interpreted. 
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 However, there are few literature reports on structure-property-biostability 
relationship in siloxane polyurethanes. This lack is particularly pronounced regarding the 
understanding of relationship between morphology and biostability. The findings documented 
in this thesis provide answers to the questions related to appropriate selection of precursors and 
their effect on morphology-biostability relationship of siloxane polyurethanes. The greater 
understanding of structure-property-biostability relationship is one of the important outcomes 
of this study and it will be useful for designing new siloxane polyurethane materials for long-
term medical implants. The outcomes of this study also provide improved understanding of the 
morphology of this class of polyurethanes, where both soft and hard segments are structurally 
more complex than those of conventional polyurethanes used in many industrial applications. 
7.2 Research outcomes 
7.2.1 Mechanical properties and phase mixing of SiPUU 
 The high degree of phase separation that leads to poor mechanical properties in 
siloxane polyurethanes.4, 5 This is attributed to the chemical incompatibility between their non-
polar soft segment and relatively polar hard segment. Incorporation of a second macrodiol 
helped in reducing the degree of phase separation and  produced siloxane polyurethanes with 
good mechanical properties required for medical implant applications.1-3, 6, 7  However, for 
heart valve application, the material requires much improved creep resistance, tensile and tear 
strengths. Therefore, the aim of this PhD project was to tailor the soft segment of mixed-
macrodiol based siloxane polyurethane by introducing a polar functionality. This modification 
enhanced the compatibility between soft and hard segments and produced siloxane 
polyurethanes with improved mechanical properties.   
The technology of synthesis, thermal and mechanical properties of synthesized SiPUU 
are documented in Chapter 3. The results clearly showed that the type of linked macrodiol in 
the soft segment influenced the mechanical properties of SiPUU. When PHMO was linked, 
SiPUU with PHMO-MDI-PHMO and PHMO-IPDI-PHMO in the soft segment showed 
improved tensile strength (31 MPa and 35 MPa, respectively) and tear strength (64 N/mm and 
70 N/mm, respectively).  The improvement in tensile strength of SiPUU with PHMO-MDI-
PHMO linked macrodiol was more than 90% higher that of the control where the macrodiol 
was not linked. The tensile strength was 118% for SiPUU with PHMO-IPDI-PHMO linked 
macrodiol. Tear strength of both materials improved over 100% compared to that of the control. 
Interestingly, these improvements were achieved without significant compromise in elasticity 
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and modulus. One reason for these improvements was increased intermolecular hydrogen 
bonding between soft and hard segments due to the presence of linked macrodiol. FTIR 
spectroscopy results showed minor increase in hydrogen bonded urethane and urea in SiPUU 
with linked macrodiols compared to the control. This level of increase in hydrogen bonding 
can be expected due to the introduction of urethane linkage to the soft segment through linked 
PHMO. This phenomenon was common for SiPUU with both PHMO and PDMS linked 
macrodiols. Yet another reason for improvement in tensile properties of SiPUU containing 
PHMO-linked macrodiols was more cohesive interfacial region between soft and hard 
segments due to PHMO-linked macrodiols. It is reported that the polyurethanes produced using 
mixed microdiols show three-phase morphology.8, 9 The data generated by DMA showed that 
the soft segment contained two phases which was consistent with the literature. One of the 
phases was comprised of siloxane units in PDMS while the other was mixed-phase consisting 
of PHMO or linked-PHMO, ethoxypropyl end groups of PDMS and some hard segments. Due 
to the polar nature of PHMO compared with PDMS, the linked-PHMO interacts with the hard 
segment more easily and makes more cohesive interface between soft and hard segments. This 
enhanced phase mixing attributed for bringing in improved mechanical properties in SiPUU 
synthesised using PHMO-linked macrodiols. The SiPUU synthesised using PHMO-HDI-
PHMO linked macrodiol did not have higher tensile properties than that of the control. Perhaps, 
the long non-polar aliphatic chain in HDI in the interfacial region might have impeded the 
phase mixing with the hard segment.  
SiPUU with PDMS-linked macrodiol, however did not significantly affect the 
mechanical properties. That was attributed to masking effect of polar groups of urethane 
linkages by siloxane segments. This masking prevented formation of higher number of 
intermolecular hydrogen bonding. Both DSC and DMA results supported this finding by 
confirming that the Tg of PDMS did not change significantly as a result of linking with a 
diisocyanate. DMA results showed that the PDMS glass transition temperature remained 
unchanged and phase separated regardless of linker molecule. Moreover, linking PDMS with 
one diisocyanate may not be enough to yield required polarity to improve the compatibility 
with the hard segment. TGA showed that the introduction of urethane linkage to the soft 
segment did not affect the thermal stability of SiPUU. 
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7.2.2 Surface characteristics, creep and recovery of SiPUU 
Morphology and surface characteristics of SiPUU were studied in detail using different 
instrumental techniques. Creep and recovery of these materials were also investigated.  The 
findings are documented in Chapter 4.  
Creep and recovery of these SiPUU were compared with commercial siloxane 
polyurethane (Elast-EonTM 2A). SiPUU showed 70% and higher instant elastic recovery after 
removing the stress. It was found that the two SiPUU containing PHMO-MDI-PHMO and 
PHMO-IPDI-PHMO linked macrodiols in the soft segment showed improved resistance to 
creep deformation. They showed better creep resistance and recovery when compared with 
Elast-EonTM 2A and the control (without linked macrodiols). The lowest unrecoverable strain 
in SiPUU with linked macrodiols was attributed to the presence of urethane linkages in the soft 
segment. The presence of urethane linkages in the soft segment increased the intermolecular 
interactions with urethane and urea linkages in the hard segment through hydrogen bonding. 
These interactions were not observed in Elast-EonTM 2A and the control. These interactions 
reduced the movement (slippage) of molecular chains responsible for permanent deformation. 
The SAXS/WAXS findings further confirmed that SiPUU with PHMO-linked macrodiols had 
improved mixed-phase morphology. This mixed-phase morphology was due to strengthening 
of the interfacial region by linked-PHMO. All the above documented observations indicated 
that linked-PHMO improved the segmental mixing of hard segment and siloxane-containing 
soft segments due to enhanced interfacial adhesion. All the SiPUU synthesised in this work 
had desirable siloxane enriched surfaces with hydrophobic characteristics. They exhibited low 
water uptake (0.7% w/w of dry mass) which was comparable to Elast-EonTM2A. 
Hydrophobicity is a desired characteristic for a material designed for medical implants as 
hydrophilicity accelerates the hydrolytic degradation.   
7.2.3 Oxidative stability of SiPUU under simulated in vitro environment 
Once a new material is synthesised, it is essential to evaluate its biostability before 
using it to develop a medical implant. Accelerated in vitro assessment is considered an 
important method to screen the material before in vivo evaluation. In this study, a well-
established in vitro oxidative test protocol10 was used to compare the biostability of the 
synthesised SiPUU together with commercially available polyurethanes. The SiPUU 
synthesised with PHMO-MDI-PHMO and PHMO-IPDI-PHMO linked macrodiols were 
selected for evaluation of oxidative stability, as these two materials showed improved tensile 
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properties. Oxidative stability of these two SiPUU was evaluated with that of commercially 
available siloxane polyurethane (Elast-EonTM 2A), polyether polyurethane (ChronoThane PTM 
80A) and polycarbonate polyurethane (ChronoSilTM 80A). The effect of the linker molecule 
introduced to the soft segment of SiPUU on biostability was discussed using the data obtained 
from these oxidative stability tests (Chapter 5). 
The SEM images showed extensive surface cracking of ChronoThane PTM 80A after 90 
days. This surface cracking occurred due to chain scission induced by oxidation of highly 
susceptible ether linkage adjacent to methylene carbon.11, 12 ChronoSilTM 80A showed some 
degree of oxidative stability compared with conventional polycarbonate polyurethane, because 
of the presence of small amount (5%, w/w) of siloxane. Elast-EonTM2A, SiPUU synthesised 
with PHMO-MDI and PHMO-IPDI linked macrodiols did not show noticeable surface 
degradation after 90 days of oxidative treatment. FTIR spectroscopic data exhibited that two 
SiPUU materials and Elast-EonTM2A showed only minimal chemical changes on the structure 
of the soft segment and there was no evidence of degradation of hard segment. However, GPC 
analysis showed that there was significant decrease in molecular weight in SiPUU and Elast-
EonTM2A with oxidation. This decrease in molecular weight  was due to different degree of 
hydrolysis of allophanate and biurete linkages as reported earlier.13 The results showed that the 
reduction of tensile strength occurred in Elast-EonTM 2A and SiPUU synthesised using PHMO-
MDI-PHMO linked macrodiol occurred in similar degree (13-14% on 90 days). However, there 
was a significant reduction of tensile strength (21%) in SiPUU synthesised from PHMO-IPDI-
PHMO linked macrodiol.  
Overall, the data presented in Chapter 5 showed that the SiPUU synthesised using 
PHMO-MDI-PHMO linked macrodiol had similar resistance to oxidative degradation 
compared with Elast-EonTM2A. It showed improved in vitro oxidative stability over polyether 
(ChronoThane PTM 80A) and polycarbonate (ChronoSilTM 80A) polyurethanes. The chemical 
modification of the soft segment did not affect the biostability of the SiPUU. As Elast-
EonTM 2A has proven record of long-term biostability,13, 14 this newly synthesised SiPUU is 
expected to possess a similar long-term stability in cardiovascular applications.  
7.2.4 Effect of chain extender composition on morphology, mechanical properties and 
oxidative stability  
The content in Chapter 6 documents the effect of two chain extenders (BHTD and 
EDA) on the phase morphology and oxidative stability of SiPUU. Use of BHTD in the hard 
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segment further improved segmental compatibility and the biostability of synthesised SiPUU.15 
A number of SiPUU were synthesised by varying BHTD-to-EDA ratio. The composition of 
the soft segment was kept constant by using PHMO-MDI-PHMO linked macrodiol and PDMS 
(20:80 w/w) as it gave the best mechanical properties. The effect of chain extender ratio on the 
morphology of hard segment, tensile properties and biostability of SiPUU synthesised with 
PHMO-MDI-PHMO linked macrodiol was presented in Chapter 6.   
The results showed that the composition of chain extender affected both morphology 
and the tensile properties of SiPUU. The SiPUU synthesised using 40 to 60 mol-% BHTD 
produced the best combination of mechanical properties with high tear and tensile strengths, 
low modulus and high elongation. The observed differences in the tensile properties were 
attributed to the number of urethane and urea linkages formed by EDA and BHTD. Increase of 
tear strength was proportional to the amount of EDA due to strong bidentate intermolecular 
hydrogen bonding from biuret linkages. DSC analysis confirmed that the ordering of the hard 
domains and tear strength depended upon EDA amount. However, all synthesised SiPUU 
showed good oxidative stability irrespective of composition of their hard segment. ATR-FTIR 
spectra did not show any noticeable chemical changes on the surface of SiPUU due to the 
degradation of soft or hard segment after in vitro treatment. Loss in tensile strength when 
subjected to in vitro oxidation treatment increased with the decreased BHTD content. That is 
expected as BHTD provides greater resistance to degradation due to the increased siloxane 
content. The loss in tensile strength was associated to hard segment disruption.  
7.3 Contribution of this thesis to the body of knowledge and to industry 
This thesis has made significant contribution to the body of the knowledge and has 
provided valuable insights on synthesis and characterisation of siloxane containing PU. The 
advances made in the body of knowledge will greatly benefit to the industry that manufactures 
heart valves and other implants. These aspects are documented below. 
7.3.1 To the knowledge 
1. To date, there is a limited literature dealing with morphology and surface property 
relationship of mixed-macrodiol based polyurethanes. This research fills this gap in 
knowledge and contributes to the fundamental understanding of structure-morphology 
relationship of mixed-macrodiol based siloxane containing polyurethanes. 
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2. Synthesis techniques described in the thesis are useful to the polymer chemists in 
synthesising polyurethanes where combination of multiple precursors with different 
reactivities is required. Furthermore, the modified solution polymerization technique 
allows the preparation of gel-free poly(urethane urea) solutions in high molecular 
weight.   
3. The new approach of linking a macrodiol to improve mechanical properties is also 
noteworthy. The contribution to the science underpinning the selection of linker 
molecule based on its chemical structure is also significant. 
4. Morphology of polyurethane is important in determining the biostability. In this aspect, 
this thesis provides better understanding of structure-property-biostability relationship 
of SiPUU in designing next generation medical implants. 
7.3.2 To the industry 
1. Chapter 316 and Chapter 417 provide technology for synthesising and validate structure-
property-morphology relationships of siloxane poly(urethane urea)s for long-term 
medical implants. These materials were formulated to meet the property specification 
required for synthetic heart valves. However, mechanical property and morphology 
data documented in this thesis also provide important information to formulation 
chemists working in biomedical field to select and tailor materials for a broad range of 
medical applications.  
2. Biostable materials with high strength and flexibility are required for cardiovascular 
application such as heart valves. The existing commercially available materials do not 
fulfil all these requirements. Biostability is critical for materials for long-term 
performance. Chapter 518 provides in vitro oxidative stability data of newly developed 
SiPUU which is comparable to a material with proven long-term biostability (Elast-
EonTM 2A). The findings reported in this chapter are expected to useful for regulatory 
approval for the material with additional testing such as in vivo stability and clinical 
trials. 
3. The findings documented in Chapter 619 provide valuable information on morphology, 
tensile properties and biostability as a function of composition of hard segment of 
SiPUU. The formulation strategy discussed in this chapter provides validated protocols 
for designing materials for medical applications with different property specifications.   
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Four research papers have been produced from this thesis, out of which three are published 
in refereed journals. The fourth research paper was accepted for publication. Also, this author 
has made substantial contribution to the comprehensive review paper (Polymer Reviews, DOI: 
10.1080/15583724.2018.1493694)20 published by the supervisory team in which she is the 
second author. Overall, this thesis provides underpinning science as well as the technology to 
synthesise and produce polyurethanes with improved mechanical properties for biomedical 
applications. Furthermore, the thesis provides fundamental understanding of the structure-
property-biostability relationship of siloxane poly(urethane urea)s, an area that has not been 
adequately researched. 
7.4 Recommendations for the future work 
The following work is recommended for future studies on this family of siloxane 
polyurethanes.  
1. Advanced mechanical testing such as fatigue resistance under cyclic loading is 
important for a material intended for heart valve application. A systematic study on the 
weakening of structure and function of SiPUU materials under repeated loading and 
unloading is recommended. This is because valve leaflets undergo millions of open-
close cycles in real life situation.  
2. Accelerated in vitro biostability tests used in this study is used as first level screening 
which must be followed with appropriate in vivo testing. The interaction of SiPUU with 
the prevailing factors in in vivo situation are expected to be more complex compared to 
in vitro environment. Thus, it is recommended that the biostability of SiPUU be 
evaluated in in vivo using appropriate animal models. In vivo test is more reliable and 
critical for a promising new material before use in medical applications.    
3. The mechanical properties of SiPUU, e.g. tear strength, can be further improved by 
using crosslinking techniques such as photo-induced cross linking. Photo-
polymerizable functional groups can be introduced in soft segment by using well-
established chemical methods. This important aspect has not been received research 
attention with respect to this class of siloxane polyurethane. Thus, it is recommended 
that future research considering crosslinking of SiPUU, especially using photo-induced 
crosslinking to develop materials with further improved mechanical properties. 
The new materials reported in this study has a limitation in that they can only be 
processed using solvent based fabrication methods. If a process could be developed 
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where the materials may be synthesized using a solvent-free process the use of the 
materials can be extended to a wide range of applications.  
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